Infinity Pharmaceuticals, Inc. Expired Patents
1 granted patents the USPTO lists as expired; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-05-02: Application 15585038; Invention METHODS OF USE OF CYCLOPAMINE ANALOGS; Applicant Infinity Pharmaceuticals, Inc.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-05-02 | 15585038 | METHODS OF USE OF CYCLOPAMINE ANALOGS | Infinity Pharmaceuticals, Inc. | Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 | 2018-08-14 | 10045970 | US20170360763A1 | Alfredo C. Castro Michael J. Grogan Karen J. McGovern Martin R. Tremblay | United States United States United States United States | REESE, HEIDI L |